Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CID5721353 (BCL6 inhibitor) is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove.
説明 | CID5721353 (BCL6 inhibitor) is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor) that disrupts BCL6/corepressor complexes in vitro and in vivo, and was shown to bind the critical site within the BTB groove. |
ターゲット&IC50 | BCL6:212 μM |
別名 | BCL6 inhibitor |
分子量 | 457.28 |
分子式 | C15H9BrN2O6S2 |
CAS No. | 301356-95-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.33 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CID5721353 301356-95-6 Apoptosis BCL Inhibitor BCL6 inhibitor Bcl-2 Family CID 5721353 CID-5721353 inhibit inhibitor